Skin Autofluorescence, a Noninvasive Biomarker of Advanced Glycation End-products, Is Associated With Frailty: The Rotterdam Study.

"Conflict of Interest None declared."

"Funding The Rotterdam Study (RS) is supported by Erasmus Medical Center and Erasmus University, Rotterdam, The Netherlands Organization for the Health Research and Development (ZonMw), the Research Institute for Diseases in the Elderly (RIDE), the Netherlands Genomics Initiative, the Ministry of Education, Culture and Science, the Ministry for Health, Welfare and Sports, the European Commission (DG XII), and the Municipality of Rotterdam. F.R. is supported by the Netherlands Scientific Organization (NWO) and ZonMW Project number NWO/ZONMW-VIDI-016-136-367. The Jaap Schouten Foundation, Rotterdam, The Netherlands, kindly provided funding for the analysis of advanced glycation end-products related to musculoskeletal health in the RS. The funding sources had no role in the study design, data collection, analysis, interpretation, writing of the report, or decision to submit the article for publication."